| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Lin Shao-Lee Chief Executive Officer | Purchase | +136,359 | +100.00%136,359 | $7.33 | $999,966 | View SEC filing | |
| 2026-01-02 | Sarraf Pasha Director | Purchase | +323,857 | +100.00%323,857 | $0.31 | $99,747 | View SEC filing | |
| 2024-12-18 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | +22.29%164,578 | $1.03 | $30,900 | View SEC filing | |
| 2023-08-29 | Suri Anish PRESIDENT AND CSO | Purchase | +4,000 | +3.04%135,638 | $2.76 | $11,040 | View SEC filing | |
| 2023-08-16 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +3,000 | +2.28%134,578 | $2.86 | $8,580 | View SEC filing | |
| 2023-03-27 | Kiener Peter A Director | Sale | -9,325 | -96.31%357 | $3.28 | $30,586 | View SEC filing | |
| 2022-05-31 | Morich Frank Director | Purchase | +28,000 | +100.00%28,000 | $3.75 | $105,000 | View SEC filing | |
| 2022-05-25 | Fletcher Aaron G.L. Director | Purchase | +205,000 | +27.89%940,000 | $3.47 | $711,700 | View SEC filing | |
| 2022-04-04 | Fletcher Aaron G.L. Director | Purchase | +735,000 | +100.00%735,000 | $4.76 | $3,498,600 | View SEC filing | |
| 2021-11-17 | Kiener Peter A Director | Sale | -20,176 | -100.00%0 | $17.93 | $361,690 | View SEC filing | |
| 2021-11-17 | Suri Anish President and CSO | Sale | -8,000 | -7.84%94,038 | $18.05 | $144,400 | View SEC filing | |
| 2021-11-15 | Suri Anish President and CSO | Sale | -20,000 | -17.54%94,038 | $15.07 | $301,354 | View SEC filing | |
| 2021-10-05 | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Sale | -1,251 | -10.67%10,472 | $14.21 | $17,783 | View SEC filing | |
| 2021-09-27 | Suri Anish PRESIDENT AND CSO | Sale | -20,000 | -21.09%74,838 | $15.23 | $304,646 | View SEC filing | |
| 2021-09-27 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +3,400 | +6.54%55,377 | $14.72 | $50,051 | View SEC filing | |
| 2021-03-17 | Pienta Kenneth Chief Medical Officer | Sale | -13,439 | -86.67%2,000 | $15.10 | $202,894 | View SEC filing | |
| 2021-02-18 | Pienta Kenneth Chief Medical Officer | Sale | -20,274 | -88.89%2,000 | $15.13 | $306,767 | View SEC filing | |
| 2021-02-18 | Pienta Kenneth Chief Medical Officer | Sale | -2,720 | -57.63%2,000 | $15.07 | $40,980 | View SEC filing | |
| 2021-01-22 | Pienta Kenneth Chief Medical Officer | Purchase | +2,720 | +136.00%4,720 | $15.07 | $40,980 | View SEC filing | |
| 2020-11-25 | Fletcher Aaron G.L. Director | Purchase | +6,548 | +4.13%165,000 | $12.64 | $82,776 | View SEC filing | |
| 2020-10-01 | Gray Cameron Director | Purchase | +10,000 | +1.50%677,500 | $15.15 | $151,500 | View SEC filing | |
| 2020-08-10 | Sandercock Colin SVP, General Counsel and Sec | Sale | -13,374 | -43.85%17,125 | $20.00 | $267,480 | View SEC filing | |
| 2020-08-07 | Sandercock Colin SVP, General Counsel and Sec | Sale | -13,274 | -43.67%17,125 | $20.00 | $265,480 | View SEC filing | |
| 2020-08-07 | Suri Anish President and CSO | Sale | -800 | -2.26%34,558 | $20.01 | $16,008 | View SEC filing | |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Sale | -6,626 | -27.28%17,125 | $20.00 | $132,530 | View SEC filing |
1-25 of 53
